Trial intelligence / Profile preview

Keppra for tremor in multiple sclerosis

2005-003903-35Phase 4Completed

Sponsor
Newcastle Hospitals NHS Foundation Trust
Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of levetiracetam in multiple sclerosis (MS), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Objective tremor assessment by accelerometry and surface EMG, Rest task tremor assessment and 4 more. Started Dec 2005; status: completed.

02

Drugs

levetiracetam
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on 2005-003903-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003903-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call